Steve Harbin's Appointment

At bioMérieux, Steve Harbin’s mission will be to deliver the Quality policy and drive a greater emphasis on environmental, risk management and internal control strategies.

Steve Harbin reports to Stéphane Bancel, Chief Executive Officer of bioMérieux. He is a member of bioMérieux’s Management Committee and also a member of the Sustainable Development Committee. “Steve’s exceptional leadership qualities and international experience in the pharmaceutical industry will help drive bioMérieux’s initiatives in Quality and in the Environment to new levels of performance. We are very pleased to have him on board,” stated Stéphane Bancel.

Of British nationality, Steve Harbin is a graduate of the Durham College of Agriculture, in the U.K. Before joining bioMérieux, Steve Harbin was Director, Global Training and Development, Manufacturing and Quality at Eli Lilly (Indianapolis, Indiana - U.S.A.) since 2003. Aged 50, he joined the pharmaceutical group in 1985 where he held management positions within the group’s industrial divisions, in Manufacturing in the U.K. and in Business Development for the Europe, Middle East and Africa region.

About bioMérieux

Advancing Diagnostics to Improve Public Health

A world leader in the field of in vitro diagnostics for 45 years, bioMérieux is present in more than 150 countries through 38 subsidiaries and a large network of distributors. In 2007, revenues reached €1.063 billion with 84% of sales outside of France.

bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cardiovascular emergencies and cancer screening and monitoring. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the NYSE Euronext Paris market (Code: BIM – Code ISIN: FR0010096479). Other information can be found at www.biomerieux.com.

bioMérieux Contacts

Investor Relations

bioMérieux
Isabelle Tongio
Tel: + 33 4 78 87 22 37
investor.relations@eu.biomerieux.com

LT Value
Nancy Levain
Tel: + 33 1 55 27 15 88
nancy.levain@ltvalue.com

Media Relations

bioMérieux
Koren Wolman-Tardy
Tel: + 33 4 78 87 20 08
media@eu.biomerieux.com

Image Sept
Laurence Heilbronn
Tel: + 33 1 53 70 74 64
lheilbronn@image7.fr

Thiphaine Hecketsweiler
Tel: + 33 1 53 70 74 59
thecketsweiler@image7.fr

Fleishman Hillard
Andrea Moody
Tel: + 1 919 457-0744
andrea.moody@fleishman.com